Changzhou, China

Shuo Wang

This inventor holds 1 USPTO granted patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shuo Wang. Retrieved from https://idiyas.com/inventor/shuo-wang-t90ed6ry

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shuo Wang: Innovator in Pharmaceutical Development

Introduction

Shuo Wang is a notable inventor based in Changzhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors that play a crucial role in treating various diseases.

Latest Patents

Wang holds a patent for "Processes and intermediates for preparing a Btk inhibitor." This patent discloses a process for the preparation of certain intermediates, specifically a compound of formula (I), which is useful in the preparation of a BTK inhibitor, such as ibrutinib. This innovation is vital for advancing treatment options in the pharmaceutical industry.

Career Highlights

Shuo Wang is currently employed at Janssen Pharmaceutica NV, a leading company in the pharmaceutical sector. His work focuses on developing innovative solutions that address critical health challenges. His expertise and dedication have positioned him as a valuable asset in his field.

Collaborations

Wang collaborates with esteemed colleagues, including Philip James Pye and Andras Horvath. These partnerships enhance the research and development efforts at Janssen Pharmaceutica NV, fostering an environment of innovation and excellence.

Conclusion

Shuo Wang's contributions to pharmaceutical development, particularly through his patent on BTK inhibitors, highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for future advancements in medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…